CAD 0.47
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 15.26 Thousand | 10.94 Thousand | - | - | - | - |
Gross Profit | -15.26 Thousand | -10.94 Thousand | - | - | - | - |
Operating Expenses | 5.26 Million | 1.62 Million | 1.75 Million | 1.48 Million | 1.05 Million | 1.13 Million |
Selling, General and Administrative Expenses | 5.26 Million | 1.57 Million | 1.75 Million | 1.47 Million | 1.05 Million | 1.13 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 45.18 Thousand | 431.19 Thousand | 10.08 Thousand | 242.42 Thousand | 252.31 Thousand |
Cost and Expenses | 5.26 Million | 1.63 Million | 1.75 Million | 1.48 Million | 1.05 Million | 1.13 Million |
Operating Income | -5.26 Million | 1.84 Million | -1.75 Million | -1.48 Million | -1.05 Million | -1.39 Million |
Interest Expense | 5724.00 | 2833.00 | - | - | - | - |
Income Tax Expense | - | 181.78 Thousand | -22.29 Thousand | -20.25 Thousand | -15.76 Thousand | -510.46 Thousand |
Earnings before Tax | -5.67 Million | 1.65 Million | -1.3 Million | -999.99 Thousand | -800.98 Thousand | -880.6 Thousand |
Net Income | -6 Million | 1.65 Million | -1.28 Million | -979.74 Thousand | -785.21 Thousand | -370.14 Thousand |
Earnings Per Share Basic | -0.04 | 0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
Earnings Per Share Diluted | -0.04 | 0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
Weighted Average Shares Outstanding | 148.44 Million | 83.45 Million | 63.68 Million | 53.24 Million | 35.12 Million | 31.98 Million |
Weighted Average Shares Outstanding (Diluted) | 140.42 Million | 83.45 Million | 63.68 Million | 53.24 Million | 35.12 Million | 31.98 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -5.27 Million | -30.44 Million | -1.3 Million | -999.99 Thousand | -800.97 Thousand | -880.6 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | 15.26 Thousand | -775.00 | 549.00 | 7567.00 |
Gross Profit | - | - | -15.26 Thousand | 775.00 | -549.00 | -7567.00 |
Operating Expenses | 745.22 Thousand | 736.5 Thousand | 5.86 Million | 2.77 Million | 845.68 Thousand | 1.1 Million |
Selling, General and Administrative Expenses | 2.52 Million | 736.5 Thousand | - | 2.77 Million | 704.33 Thousand | 862.13 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -1.77 Million | -5750.00 | - | - | 7510.00 | 12.23 Thousand |
Cost and Expenses | 745.22 Thousand | 736.5 Thousand | 5.87 Million | 2.77 Million | 846.23 Thousand | 1.11 Million |
Operating Income | -691.19 Thousand | -736.5 Thousand | -5.87 Million | -2.77 Million | -829.46 Thousand | -1.09 Million |
Interest Expense | - | - | 5724.00 | -40.19 Thousand | - | 13.39 Thousand |
Income Tax Expense | -324.98 Thousand | 153.88 Thousand | 315 Thousand | 315 Thousand | 40.13 Thousand | 13.39 Thousand |
Earnings before Tax | -693.37 Thousand | -732.25 Thousand | -5.67 Million | -3.26 Million | -592.34 Thousand | -353.15 Thousand |
Net Income | -368.38 Thousand | -886.13 Thousand | -5.99 Million | -3.58 Million | -592.34 Thousand | -353.15 Thousand |
Earnings Per Share Basic | -0.00 | -0.01 | - | -0.02 | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.01 | - | -0.02 | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 154.91 Million | 151.88 Million | 140.42 Million | 151.79 Million | 141.9 Million | 138.89 Million |
Weighted Average Shares Outstanding (Diluted) | 154.91 Million | 151.88 Million | 140.42 Million | 151.79 Million | 141.9 Million | 138.89 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -691.19 Thousand | -736.5 Thousand | - | -2.77 Million | -828.91 Thousand | -1.08 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
MAT
ATOXF
7593
BPFI
FRBK
TRYRF